 | • レポートコード：MRC2-11QY12555 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はループス治療のグローバル市場について調査・分析したレポートです。種類別（B細胞モジュレーター、T細胞モジュレーター、免疫抑制剤・細胞毒性薬、炎症誘発性・サイトカイン阻害剤、その他）市場規模、用途別（クリニック、病院、診療所研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ループス治療の競争状況、市場シェア ・世界のループス治療市場：種類別市場規模 2015年-2020年（B細胞モジュレーター、T細胞モジュレーター、免疫抑制剤・細胞毒性薬、炎症誘発性・サイトカイン阻害剤、その他） ・世界のループス治療市場：種類別市場規模予測 2021年-2026年（B細胞モジュレーター、T細胞モジュレーター、免疫抑制剤・細胞毒性薬、炎症誘発性・サイトカイン阻害剤、その他） ・世界のループス治療市場：用途別市場規模 2015年-2020年（クリニック、病院、診療所研究所） ・世界のループス治療市場：用途別市場規模予測 2021年-2026年（クリニック、病院、診療所研究所） ・北米のループス治療市場分析：米国、カナダ ・ヨーロッパのループス治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのループス治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のループス治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのループス治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：F.Hoffmann-La Roche、GlaxoSmithKline、Medlmmune、Pfizer、ADMA Biologics、Amgen、Anthera Pharmaceuticals、Bayer HealthCare、Biogen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Systemic lupus erythematosus (SLE) is an autoimmune disease that causes a chronic inflammatory condition.
According to the report, one of the major drivers for this market is high prevalence rate.
Market Analysis and Insights: Global Lupus Therapeutic Market
The global Lupus Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Lupus Therapeutic Scope and Market Size
Lupus Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lupus Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
F.Hoffmann-La Roche
GlaxoSmithKline
Medlmmune
Pfizer
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer HealthCare
Biogen
Market segment by Type, the product can be split into
B-Cell Modulators
T-Cell Modulators
Immunosuppressive And Cytotoxic Drugs
Proinflammatory And Cytokine Inhibitors
Others
Market segment by Application, split into
Clinics
Hospitals
Physicians’ Office Laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Lupus Therapeutic Revenue
1.4 Market by Type
1.4.1 Global Lupus Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 B-Cell Modulators
1.4.3 T-Cell Modulators
1.4.4 Immunosuppressive And Cytotoxic Drugs
1.4.5 Proinflammatory And Cytokine Inhibitors
1.4.6 Others
1.5 Market by Application
1.5.1 Global Lupus Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Physicians’ Office Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Lupus Therapeutic Market Perspective (2015-2026)
2.2 Global Lupus Therapeutic Growth Trends by Regions
2.2.1 Lupus Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Lupus Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Lupus Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Lupus Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Lupus Therapeutic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Lupus Therapeutic Players by Market Size
3.1.1 Global Top Lupus Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Lupus Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Lupus Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Lupus Therapeutic Market Concentration Ratio
3.2.1 Global Lupus Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Lupus Therapeutic Revenue in 2019
3.3 Lupus Therapeutic Key Players Head office and Area Served
3.4 Key Players Lupus Therapeutic Product Solution and Service
3.5 Date of Enter into Lupus Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Lupus Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Lupus Therapeutic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Lupus Therapeutic Market Size by Application (2015-2020)
5.2 Global Lupus Therapeutic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Lupus Therapeutic Market Size (2015-2020)
6.2 Lupus Therapeutic Key Players in North America (2019-2020)
6.3 North America Lupus Therapeutic Market Size by Type (2015-2020)
6.4 North America Lupus Therapeutic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Lupus Therapeutic Market Size (2015-2020)
7.2 Lupus Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Lupus Therapeutic Market Size by Type (2015-2020)
7.4 Europe Lupus Therapeutic Market Size by Application (2015-2020)
8 China
8.1 China Lupus Therapeutic Market Size (2015-2020)
8.2 Lupus Therapeutic Key Players in China (2019-2020)
8.3 China Lupus Therapeutic Market Size by Type (2015-2020)
8.4 China Lupus Therapeutic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Lupus Therapeutic Market Size (2015-2020)
9.2 Lupus Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Lupus Therapeutic Market Size by Type (2015-2020)
9.4 Japan Lupus Therapeutic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Lupus Therapeutic Market Size (2015-2020)
10.2 Lupus Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Lupus Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Lupus Therapeutic Market Size by Application (2015-2020)
11 India
11.1 India Lupus Therapeutic Market Size (2015-2020)
11.2 Lupus Therapeutic Key Players in India (2019-2020)
11.3 India Lupus Therapeutic Market Size by Type (2015-2020)
11.4 India Lupus Therapeutic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Lupus Therapeutic Market Size (2015-2020)
12.2 Lupus Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Lupus Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Lupus Therapeutic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 F.Hoffmann-La Roche
13.1.1 F.Hoffmann-La Roche Company Details
13.1.2 F.Hoffmann-La Roche Business Overview
13.1.3 F.Hoffmann-La Roche Lupus Therapeutic Introduction
13.1.4 F.Hoffmann-La Roche Revenue in Lupus Therapeutic Business (2015-2020))
13.1.5 F.Hoffmann-La Roche Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Lupus Therapeutic Introduction
13.2.4 GlaxoSmithKline Revenue in Lupus Therapeutic Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 Medlmmune
13.3.1 Medlmmune Company Details
13.3.2 Medlmmune Business Overview
13.3.3 Medlmmune Lupus Therapeutic Introduction
13.3.4 Medlmmune Revenue in Lupus Therapeutic Business (2015-2020)
13.3.5 Medlmmune Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Lupus Therapeutic Introduction
13.4.4 Pfizer Revenue in Lupus Therapeutic Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 ADMA Biologics
13.5.1 ADMA Biologics Company Details
13.5.2 ADMA Biologics Business Overview
13.5.3 ADMA Biologics Lupus Therapeutic Introduction
13.5.4 ADMA Biologics Revenue in Lupus Therapeutic Business (2015-2020)
13.5.5 ADMA Biologics Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Lupus Therapeutic Introduction
13.6.4 Amgen Revenue in Lupus Therapeutic Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Anthera Pharmaceuticals
13.7.1 Anthera Pharmaceuticals Company Details
13.7.2 Anthera Pharmaceuticals Business Overview
13.7.3 Anthera Pharmaceuticals Lupus Therapeutic Introduction
13.7.4 Anthera Pharmaceuticals Revenue in Lupus Therapeutic Business (2015-2020)
13.7.5 Anthera Pharmaceuticals Recent Development
13.8 Bayer HealthCare
13.8.1 Bayer HealthCare Company Details
13.8.2 Bayer HealthCare Business Overview
13.8.3 Bayer HealthCare Lupus Therapeutic Introduction
13.8.4 Bayer HealthCare Revenue in Lupus Therapeutic Business (2015-2020)
13.8.5 Bayer HealthCare Recent Development
13.9 Biogen
13.9.1 Biogen Company Details
13.9.2 Biogen Business Overview
13.9.3 Biogen Lupus Therapeutic Introduction
13.9.4 Biogen Revenue in Lupus Therapeutic Business (2015-2020)
13.9.5 Biogen Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Lupus Therapeutic Key Market Segments
Table 2. Key Players Covered: Ranking by Lupus Therapeutic Revenue
Table 3. Ranking of Global Top Lupus Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Lupus Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of B-Cell Modulators
Table 6. Key Players of T-Cell Modulators
Table 7. Key Players of Immunosuppressive And Cytotoxic Drugs
Table 8. Key Players of Proinflammatory And Cytokine Inhibitors
Table 9. Key Players of Others
Table 10. Global Lupus Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Lupus Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Lupus Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Lupus Therapeutic Market Share by Regions (2015-2020)
Table 14. Global Lupus Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Lupus Therapeutic Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Lupus Therapeutic Market Growth Strategy
Table 20. Main Points Interviewed from Key Lupus Therapeutic Players
Table 21. Global Lupus Therapeutic Revenue by Players (2015-2020) (Million US$)
Table 22. Global Lupus Therapeutic Market Share by Players (2015-2020)
Table 23. Global Top Lupus Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lupus Therapeutic as of 2019)
Table 24. Global Lupus Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Lupus Therapeutic Product Solution and Service
Table 27. Date of Enter into Lupus Therapeutic Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Lupus Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 30. Global Lupus Therapeutic Market Size Share by Type (2015-2020)
Table 31. Global Lupus Therapeutic Revenue Market Share by Type (2021-2026)
Table 32. Global Lupus Therapeutic Market Size Share by Application (2015-2020)
Table 33. Global Lupus Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 34. Global Lupus Therapeutic Market Size Share by Application (2021-2026)
Table 35. North America Key Players Lupus Therapeutic Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Lupus Therapeutic Market Share (2019-2020)
Table 37. North America Lupus Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 38. North America Lupus Therapeutic Market Share by Type (2015-2020)
Table 39. North America Lupus Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 40. North America Lupus Therapeutic Market Share by Application (2015-2020)
Table 41. Europe Key Players Lupus Therapeutic Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Lupus Therapeutic Market Share (2019-2020)
Table 43. Europe Lupus Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Lupus Therapeutic Market Share by Type (2015-2020)
Table 45. Europe Lupus Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Lupus Therapeutic Market Share by Application (2015-2020)
Table 47. China Key Players Lupus Therapeutic Revenue (2019-2020) (Million US$)
Table 48. China Key Players Lupus Therapeutic Market Share (2019-2020)
Table 49. China Lupus Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 50. China Lupus Therapeutic Market Share by Type (2015-2020)
Table 51. China Lupus Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 52. China Lupus Therapeutic Market Share by Application (2015-2020)
Table 53. Japan Key Players Lupus Therapeutic Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Lupus Therapeutic Market Share (2019-2020)
Table 55. Japan Lupus Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Lupus Therapeutic Market Share by Type (2015-2020)
Table 57. Japan Lupus Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Lupus Therapeutic Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Lupus Therapeutic Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Lupus Therapeutic Market Share (2019-2020)
Table 61. Southeast Asia Lupus Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Lupus Therapeutic Market Share by Type (2015-2020)
Table 63. Southeast Asia Lupus Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Lupus Therapeutic Market Share by Application (2015-2020)
Table 65. India Key Players Lupus Therapeutic Revenue (2019-2020) (Million US$)
Table 66. India Key Players Lupus Therapeutic Market Share (2019-2020)
Table 67. India Lupus Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 68. India Lupus Therapeutic Market Share by Type (2015-2020)
Table 69. India Lupus Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 70. India Lupus Therapeutic Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Lupus Therapeutic Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Lupus Therapeutic Market Share (2019-2020)
Table 73. Central & South America Lupus Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Lupus Therapeutic Market Share by Type (2015-2020)
Table 75. Central & South America Lupus Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Lupus Therapeutic Market Share by Application (2015-2020)
Table 77. F.Hoffmann-La Roche Company Details
Table 78. F.Hoffmann-La Roche Business Overview
Table 79. F.Hoffmann-La Roche Product
Table 80. F.Hoffmann-La Roche Revenue in Lupus Therapeutic Business (2015-2020) (Million US$)
Table 81. F.Hoffmann-La Roche Recent Development
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Product
Table 85. GlaxoSmithKline Revenue in Lupus Therapeutic Business (2015-2020) (Million US$)
Table 86. GlaxoSmithKline Recent Development
Table 87. Medlmmune Company Details
Table 88. Medlmmune Business Overview
Table 89. Medlmmune Product
Table 90. Medlmmune Revenue in Lupus Therapeutic Business (2015-2020) (Million US$)
Table 91. Medlmmune Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Product
Table 95. Pfizer Revenue in Lupus Therapeutic Business (2015-2020) (Million US$)
Table 96. Pfizer Recent Development
Table 97. ADMA Biologics Company Details
Table 98. ADMA Biologics Business Overview
Table 99. ADMA Biologics Product
Table 100. ADMA Biologics Revenue in Lupus Therapeutic Business (2015-2020) (Million US$)
Table 101. ADMA Biologics Recent Development
Table 102. Amgen Company Details
Table 103. Amgen Business Overview
Table 104. Amgen Product
Table 105. Amgen Revenue in Lupus Therapeutic Business (2015-2020) (Million US$)
Table 106. Amgen Recent Development
Table 107. Anthera Pharmaceuticals Company Details
Table 108. Anthera Pharmaceuticals Business Overview
Table 109. Anthera Pharmaceuticals Product
Table 110. Anthera Pharmaceuticals Revenue in Lupus Therapeutic Business (2015-2020) (Million US$)
Table 111. Anthera Pharmaceuticals Recent Development
Table 112. Bayer HealthCare Business Overview
Table 113. Bayer HealthCare Product
Table 114. Bayer HealthCare Company Details
Table 115. Bayer HealthCare Revenue in Lupus Therapeutic Business (2015-2020) (Million US$)
Table 116. Bayer HealthCare Recent Development
Table 117. Biogen Company Details
Table 118. Biogen Business Overview
Table 119. Biogen Product
Table 120. Biogen Revenue in Lupus Therapeutic Business (2015-2020) (Million US$)
Table 121. Biogen Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lupus Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. B-Cell Modulators Features
Figure 3. T-Cell Modulators Features
Figure 4. Immunosuppressive And Cytotoxic Drugs Features
Figure 5. Proinflammatory And Cytokine Inhibitors Features
Figure 6. Others Features
Figure 7. Global Lupus Therapeutic Market Share by Application: 2020 VS 2026
Figure 8. Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Physicians' Office Laboratories Case Studies
Figure 11. Lupus Therapeutic Report Years Considered
Figure 12. Global Lupus Therapeutic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Lupus Therapeutic Market Share by Regions: 2020 VS 2026
Figure 14. Global Lupus Therapeutic Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Lupus Therapeutic Market Share by Players in 2019
Figure 17. Global Top Lupus Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lupus Therapeutic as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Lupus Therapeutic Revenue in 2019
Figure 19. North America Lupus Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Lupus Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Lupus Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Lupus Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Lupus Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Lupus Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Lupus Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
全身性エリテマトーデス（SLE）治療薬の世界市場（～2026年） SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces …- ループス腎炎の世界市場（～2026年） Lupus nephritis refers to the kidney damage caused by the disease lupus erythematosus. Lupus erythematosus is an autoimmune disease where the immune system turns against the body, affecting vital organs. Systemic lupus erythematosus affects the kidneys, joints, skin, and brain and can be fatal. Whil…
- サイトメガロウイルス（HHV-5）感染症治療薬の世界市場（～2026年） A drug used to treat giant cell infections. Market Analysis and Insights: Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market The global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of X…
- 眼科用治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ophthalmic Therapeutic Drugs Market The global Ophthalmic Therapeutic Drugs market size is projected to reach US$ 16740 million by 2026, from US$ 15860 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Ophthalmic Therapeutic Drugs Scope and Market Size…
- リンパ芽球性リンパ腫治療薬の世界市場（～2026年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…